期刊文献+

Predictors of Complete Early Virological Response to Pegylated Interferon and Ribavirin in Egyptian Patients with Chronic Hepatitis C Genotype 4

Predictors of Complete Early Virological Response to Pegylated Interferon and Ribavirin in Egyptian Patients with Chronic Hepatitis C Genotype 4
下载PDF
导出
摘要 We aim to determine the baseline factors associated with partial and cEVR by analyzing the data of 1861 Egyptian patients treated for 12 weeks with a course of Peg-IFN plus RBV. Base line data of 1861 Egyptian patients with chronic hepatitis C coming at Cairo-Fatemic Hospital for HCV treatment were studied including full clinical, Ultrasonographic examination, laboratory evaluation and liver biopsy. The most significant variables in relation to complete early virological response were low Hb level (13 gm/dl) with p 0.01, the stage of fibrosis p value < 0.05 and the grades of inflammation p value were associated with less achievement of c EVR. We conclude that identifying the most significant predictors of response such as Hb, stage of fibrosis F, at baseline before initiating treatment is mandatory to predict which patient will be more expected to achieve a cEVR and thus reducing the side-effects and healthcare costs associated with interferon therapies. We aim to determine the baseline factors associated with partial and cEVR by analyzing the data of 1861 Egyptian patients treated for 12 weeks with a course of Peg-IFN plus RBV. Base line data of 1861 Egyptian patients with chronic hepatitis C coming at Cairo-Fatemic Hospital for HCV treatment were studied including full clinical, Ultrasonographic examination, laboratory evaluation and liver biopsy. The most significant variables in relation to complete early virological response were low Hb level (13 gm/dl) with p 0.01, the stage of fibrosis p value < 0.05 and the grades of inflammation p value were associated with less achievement of c EVR. We conclude that identifying the most significant predictors of response such as Hb, stage of fibrosis F, at baseline before initiating treatment is mandatory to predict which patient will be more expected to achieve a cEVR and thus reducing the side-effects and healthcare costs associated with interferon therapies.
出处 《Advances in Infectious Diseases》 2013年第2期78-83,共6页 传染病进展(英文)
关键词 PREDICTORS of Response cEVR HCV Treatment PEG IFN/Ribavirin Predictors of Response cEVR HCV Treatment Peg IFN/Ribavirin
  • 相关文献

参考文献1

二级参考文献37

  • 1[1]Farci P,Purcell RH.Clinical significance of hepatitis C virus genotypes and quasispecies.Semin Liver Dis 2000; 20:103-126
  • 2[2]Lyra AC,Ramrakhiani S,Bacon BR,Di Bisceglie AM.Infection with hepatitis C virus genotype 4 in the United States.J Clin Gastroenterol 2004; 38:68-71
  • 3[3]el-Zayadi A,Simmonds P,Dabbous H,Prescott L,Selim O,Ahdy A.Response to interferon-alpha of Egyptian patients infected with hepatitis C virus genotype 4.J Viral Hepat 1996; 3:261-264
  • 4[4]Shobokshi O,Serebour FR,Skakni L,Al Jaser N,Tantawe AO,Sabah A,Dinish T,Qatani T,Sandokji A,Al-Blowi A,Karawi M,Al-Kayyal B,Al-Momen S,Akbar H,Ayoola A,El-Hazmi M,El-Hazmi M,Humaida A,Eissa H,Al-Quaiz M,Khawajah F,Al-Khalifa M.Peg-IFN Alfa-2a (40kda) As A Monotherapy or In Combination With Ribavirin Significantly Improve End Of Treatment Response Rate.In:HCV Genotype 4 Chronic Active Hepatitis (CAH) Patients.53rd AASLD 2002.Boston,MA.Hepatology 2002; 36:2
  • 5[5]Gad A,Tanaka E,Orii K,Rokuhara A,Nooman Z,Serwah AH,Shoair M,Yoshizawa K,Kiyosawa K.Relationship between hepatitis C virus infection and schistosomal liver disease:not simply an additive effect.J Gastroenterol 2001; 36:753-758
  • 6[6]Helal TE,Danial MF,Ahmed HF.The relationship between hepatitis C virus and schistosomiasis:histopathologic evaluation of liver biopsy specimens.Hum Pathol 1998; 29:743-749
  • 7[7]Shiha G,Zalata KR.Does schistosomiasis interfere with application of the Knodell score for assessment of chronic hepatitis C? Med Sci Monit 2002; 8:CR72-77
  • 8[8]Hassan MI,Kassim SK,Ali HS,Sayed el-DA,Khalifa A.Evaluation of nitric oxide (NO) levels in hepatitis C virus(HCV) infection:relationship to schistosomiasis and liver cirrhosis among Egyptian patients.Dis Markers 2002; 18:137-142
  • 9[9]Sherman M.Response To Pegasys And Regular Interferon A-2a For Individuals With Chronic HCV And Genotype 4.Virologic Response To Pegasys With Genotype 4 In Small Study Group.AASLD November 2000.Hepatology 2002; 42Suppl 1:1A-32A
  • 10[10]Shiffman ML.Pegylated interferons:what role will they play in the treatment of chronic hepatitis C? Curr Gastroenterol Rep 2001; 3:30-37

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部